Distribution and 24-hour transition of SCAI shock stages and their association with 30-day mortality in acute

Hung Manh Pham1,2, Hanh Duc Van1, Long Bao Hoang3

  • 1Vietnam National Heart Institute, Bach Mai Hospital, Hanoi, Vietnam.

Medicine
|September 15, 2023
PubMed

Insights

Monitoring Society for Cardiovascular Angiography and Interventions (SCAI) shock stages in acute myocardial infarction (AMI) patients after admission improves mortality prediction. Changes in SCAI stage within 24 hours offer crucial prognostic information for AMI patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Clinical Research

Background:

  • The Society for Cardiovascular Angiography and Interventions (SCAI) shock classification is a validated predictor of mortality in acute myocardial infarction (AMI).
  • Limited data exist on the dynamic changes in SCAI shock stages post-AMI and their correlation with patient outcomes.
  • Understanding SCAI stage transitions is crucial for refining prognostic assessments in AMI patients.

Purpose of the Study:

  • To investigate the association between transitions in SCAI shock stages and 30-day mortality in patients with AMI.
  • To determine if reevaluating SCAI stages after 24 hours provides additional prognostic value beyond initial assessment.

Main Methods:

  • A prospective study included 139 AMI patients classified by SCAI stages (A, B, C/D/E) at admission and 24 hours.
  • Kaplan-Meier estimates and multivariable Cox regression analyses were used to assess the relationship between SCAI stage changes and 30-day mortality.
  • Patients were categorized based on initial SCAI stage and changes observed within 24 hours.

Main Results:

  • On admission, 50.4% were SCAI stage A, 20.1% stage B, and 29.5% stages C/D/E.
  • After 24 hours, 14.4% improved, 66.2% remained stable, and 19.4% worsened.
  • 30-day mortality rates were 2.9% (initial A), 21.4% (initial B), and 61.0% (initial C/D/E). Mortality was significantly higher (92.6%) in patients whose SCAI stage worsened by 24 hours.

Conclusions:

  • Dynamic assessment of SCAI shock stages in AMI patients, both at admission and after 24 hours, significantly enhances 30-day mortality prediction.
  • Worsening SCAI stage within 24 hours is strongly associated with increased mortality.
  • Serial SCAI staging provides valuable prognostic information for managing AMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
200